SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: tnsaf who wrote (8817)6/18/2001 12:32:09 AM
From: Vector1  Read Replies (1) | Respond to of 9719
 
Jason, its probably a good buy especially when it dropped to around 13. Unfortunately I was busy. What concerns me is AMGNs lack of public support, Miljenko's concerns about possible immulogical responses and how totally f_ked up the FDA seems to be lately. On the other hand if approved Abarelix will imo quickly dominate the market that Lupron now owns. If it works for endometriosis it is a monster home run.

v1